IRIS UniCatt

Petito, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.310
NA - Nord America 2.122
AS - Asia 1.134
SA - Sud America 174
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 4
Totale 5.772
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.082
DE - Germania 541
IT - Italia 536
CN - Cina 469
SE - Svezia 415
SG - Singapore 351
PL - Polonia 168
BR - Brasile 161
FR - Francia 160
IE - Irlanda 103
UA - Ucraina 102
GB - Regno Unito 85
ID - Indonesia 76
IN - India 53
FI - Finlandia 52
RU - Federazione Russa 50
TR - Turchia 43
BE - Belgio 31
KR - Corea 31
CA - Canada 27
HK - Hong Kong 24
IR - Iran 18
JP - Giappone 17
NL - Olanda 17
ES - Italia 11
EU - Europa 11
AT - Austria 8
MX - Messico 8
CZ - Repubblica Ceca 7
UZ - Uzbekistan 6
IL - Israele 5
AR - Argentina 4
BD - Bangladesh 4
CI - Costa d'Avorio 4
CO - Colombia 4
NP - Nepal 4
VN - Vietnam 4
ZA - Sudafrica 4
AL - Albania 3
CH - Svizzera 3
HU - Ungheria 3
IQ - Iraq 3
KH - Cambogia 3
LT - Lituania 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EG - Egitto 2
GR - Grecia 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
GL - Groenlandia 1
IS - Islanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UG - Uganda 1
Totale 5.772
Salva come PNG Salva come JPEG
Città #
Chandler 463
Singapore 242
Ashburn 163
Warsaw 145
Cattolica 107
Dublin 103
Beijing 94
Rome 93
Jacksonville 81
Ann Arbor 77
Jakarta 76
New York 68
San Mateo 55
Wilmington 50
Los Angeles 48
Nanjing 47
Boston 45
Milan 44
Hangzhou 40
Izmir 38
Woodbridge 38
Moscow 36
Princeton 36
Marseille 35
The Dalles 35
Dearborn 34
Fairfield 31
North Bergen 29
Redwood City 27
Shanghai 27
Brussels 26
Houston 26
Munich 26
Boardman 25
Frankfurt am Main 25
Nürnberg 25
Seoul 25
Hefei 24
Seattle 24
Lawrence 23
London 22
Helsinki 21
Nuremberg 20
Nanchang 18
Kraków 17
Lancaster 17
Shenyang 17
Redmond 16
Bremen 15
Guangzhou 15
Hong Kong 15
Mountain View 14
São Paulo 14
Zhengzhou 13
Düsseldorf 12
Lauterbourg 12
Tianjin 12
Cambridge 11
Chicago 11
Fremont 11
Kish 11
Norwalk 11
Augusta 10
Hebei 10
Paris 10
Pune 10
Jiaxing 9
Kunming 9
Tokyo 9
Toronto 9
Hyderabad 8
Leawood 8
Monza 8
Washington 8
Andover 7
San Francisco 7
Trieste 7
Mexico City 6
Portsmouth 6
Rio de Janeiro 6
San Diego 6
Santa Clara 6
Verona 6
Changchun 5
Changsha 5
Falkenstein 5
Hounslow 5
Jinan 5
Newark 5
Turku 5
Vienna 5
Abidjan 4
Catania 4
Charlotte 4
Des Moines 4
Goiânia 4
Lanzhou 4
Montecorvino Rovella 4
Naples 4
Stockholm 4
Totale 3.222
Salva come PNG Salva come JPEG
Nome #
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 301
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 190
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 164
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 159
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 142
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 141
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 140
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 137
13C-octanoic acid breath test to study gastric emptying time 134
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 133
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 125
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 117
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 114
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 109
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 101
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 99
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 99
Commensal Clostridia: leading players in the maintenance of gut homeostasis 98
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 98
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 94
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 91
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 91
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 88
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 84
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 82
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 81
Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia 80
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 79
Gut microbiota and inflammatory bowel disease: an update 78
Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease 78
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 78
Tumor necrosis factor-α and solute carrier family 22 member 4 gene polymorphisms as potential determinants of intestinal dysbiosis 78
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 77
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 75
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 74
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 73
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 69
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 69
Dietary magnesium alleviates experimental murine colitis through modulation of gut microbiota 67
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 66
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 62
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease 61
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 59
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 59
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 58
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 56
Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study 56
Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma 55
Adverse Food Reactions in Inflammatory Bowel Disease: State of the Art and Future Perspectives 53
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 53
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 53
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 50
Gut–joint axis: The role of physical exercise on gut microbiota modulation in older people with osteoarthritis 50
Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure 50
An Integrative Multi-omic Analysis defines Gut Microbiota, Mycobiota and Metabolic fingerprints in Ulcerative Colitis Patients 49
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 49
The thrilling journey of sars-cov-2 into the intestine: From pathogenesis to future clinical implications 47
Bariatric procedures and microbiota: patient selection and outcome prediction 46
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 44
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 44
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 44
MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer 43
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 42
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment 41
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 40
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 39
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 38
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation 35
Functional hypothalamic amenorrhea: gut microbiota composition and the effects of exogenous estrogen administration 35
Extrachromosomal Circular DNA: An Emerging Potential Biomarker for Inflammatory Bowel Diseases? 34
Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis 32
Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach 29
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 24
[Microbiota and inflammatory bowel disease: an update.] 24
Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies 22
ToF-SIMS and principal component analysis of lipids and amino acids from inflamed and dysplastic human colonic mucosa 22
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 19
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 7
The Key Nutrients in the Mediterranean Diet and Their Effects in Inflammatory Bowel Disease: A Narrative Review 5
Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone 4
Totale 5.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020104 0 0 0 0 0 0 0 0 0 0 78 26
2020/2021390 30 35 7 35 48 25 35 10 43 20 81 21
2021/2022572 57 28 21 25 49 22 12 79 32 50 110 87
2022/20231.250 161 178 96 199 76 151 56 87 144 19 43 40
2023/2024780 46 176 29 43 32 101 49 27 43 34 85 115
2024/20251.292 42 45 136 54 143 69 86 71 225 177 244 0
Totale 5.886